vimarsana.com

Page 202 - புதியது ப்ராடக்ட்ஸ் மற்றும் சேவைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Brookfield Renewable Announces Secondary Public Offering

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Brookfield Renewable Announces Secondary Public Offering Brookfield Renewable Partners L.P.February 8, 2021 GMT BROOKFIELD, News, Feb. 08, 2021 (GLOBE NEWSWIRE) Brookfield Renewable Partners L.P. (the “Partnership”) (NYSE: BEP; TSX: BEP.UN), Brookfield Renewable Corporation (“BEPC” and together with the Partnership, “Brookfield Renewable”) (NYSE/TSX: BEPC) and Brookfield Asset Management Inc. (“Brookfield Asset Management”) (NYSE: BAM; TSX: BAM.A) announced today the commencement of a proposed secondary public offering of 15,000,000 class A exchangeable subordinate voting shares (the “Exchangeable Shares”) of BEPC by subsidiaries of Brookfield Asset Management (the “Selling Shareholders”). The Selling Shareholders expect to grant the underwriters a 30-day option to purchase up to 2,250,000 additional Exchangeable Shares. Brookfield Renewable is not selling any E

Blain s Farm & Fleet Recognized by Forbes As One of America s Best Employers For Third Year

Press release content from Business Wire. The AP news staff was not involved in its creation. Blain’s Farm & Fleet Recognized by Forbes As One of America’s Best Employers For Third Year February 9, 2021 GMT JANESVILLE, Wis. (BUSINESS WIRE) Feb 9, 2021 Blain’s Farm & Fleet is honored to announce that they have been named one of “America’s Best Midsize Employers” by Forbes magazine for the third year in a row. Forbes partnered with market research company Statista to identify which companies are best at making their employees feel happy, inspired, and well-compensated. In addition to being recognized as one of the Top 500 Midsize Employers in America, Blain’s Farm & Fleet was ranked 17 th among all “Retail and Wholesale” companies in the US.

Nature Medicine Publishes First Study Utilizing NanoString s GeoMx Digital Spatial Profiler Whole Transcriptome Atlas

Press release content from Business Wire. The AP news staff was not involved in its creation. Nature Medicine Publishes First Study Utilizing NanoString’s GeoMx Digital Spatial Profiler Whole Transcriptome Atlas February 9, 2021 GMT Nature Medicine publishes first peer-reviewed study using GeoMx DSP with next generation sequencing readout. (Photo: Business Wire) Nature Medicine publishes first peer-reviewed study using GeoMx DSP with next generation sequencing readout. (Photo: Business Wire) SEATTLE (BUSINESS WIRE) Feb 9, 2021 NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the publication of a study in the journal Nature Medicine that

Voice Services Continue to Evolve with 5G Networks

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Voice Services Continue to Evolve with 5G Networks 5G AmericasFebruary 9, 2021 GMT BELLEVUE, Wash., Feb. 09, 2021 (GLOBE NEWSWIRE) Mobile voice service continues to play an integral role in the world of mobile wireless communications. 5G Americas, the wireless industry trade association and voice of 5G and LTE for the Americas, today announced the publication of a white paper The Future of Voice in Mobile Wireless Communications, providing an update on radio access network evolution and cloud infrastructure evolution for voice services in the 5G ecosystem.

Emerald Health Pharmaceuticals Demonstrates Potential Disease-Modifying Activity of Novel

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Emerald Health Pharmaceuticals Demonstrates Potential Disease-Modifying Activity of Novel . Emerald Health PharmaceuticalsFebruary 9, 2021 GMT Data published in peer-reviewed journal, Molecular and Cellular Neuroscience show neuroprotective and neurogenic activity of proprietary product candidate, EHP-102 SAN DIEGO, CA, Feb. 09, 2021 (GLOBE NEWSWIRE) Emerald Health Pharmaceuticals Inc. (EHP or the Company), a clinical-stage biotechnology company developing a new class of medicines to treat neurodegenerative and other diseases with unmet medical needs, has published a scientific article in the peer-reviewed journal, Molecular and Cellular Neuroscience, highlighting data supporting the potential of EHP’s drug product candidate, EHP-102, to treat Parkinson’s disease (PD). EHP-102 employs a multi-modal mechanism of action, which may offer a new path to better treatment outcomes.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.